A detailed history of Eukles Asset Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Eukles Asset Management holds 45 shares of MRK stock, worth $4,471. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 45 -0.0%
Holding current value
$4,471
Previous $5,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 27, 2021

BUY
$68.86 - $81.11 $3,098 - $3,649
45 New
45 $3,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Eukles Asset Management Portfolio

Follow Eukles Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.